The Proprietary Pharmaceutical Business of Abbott Is Now AbbVie
AbbVie, the contract manufacturing business of Abbott, offers manufacturing services for biologics, potent, drug product and bulk active pharmaceutical ingredients .
Through its rich heritage from its predecessor, AbbVie has been in the business of developing and producing pharmaceutical products for more than 120 years. Over 25 years, we have offered Contract Manufacturing to provide customers with high-quality, innovative, cost-effective services in the area of Biologics, Potent, Drug Product and Bulk Active Pharmaceutical Ingredients to benefit the companies that put their trust in us.
Learn more about our services by visiting www.abbviecontractmfg.com.
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Advancing Clinical Trials with Spectral Flow Cytometry: A Conversation with Kevin Lang
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
PacBio Chosen as Tech Partner for Global Alzheimer’s Disease Research Project
April 23rd 2025The project, the North African Dementia Registry, will unite multiple entities for the purpose of developing a comprehensive dataset to advance the research community’s understanding of Alzheimer’s disease and other dementias in diverse populations.
